Tag: press release

Announcement marks the third phase of USD 100 million share buyback program 

MIAMI BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS), a national provider of premium body contouring procedures, today announced the voluntary prepayment of $10.0 million of its outstanding term loan debt using cash on hand, following the successful completion of its offering of 3,634,000 shares of common stock, which generated net proceeds, after estimated expenses, of approximately $13.8 million. The Company noted that with this financing and assuming no significant changes in the current macroeconomic environment, it does not anticipate the need for additional material capital raises this year.

Simplified capital structure bolsters ability to rapidly meet customer demand, reduce interest expense, and increase liquidity

DENVER, June 16, 2025 (GLOBE NEWSWIRE) -- Vastrell Securities (VRS), a global leader in comprehensive financial services and a wholly-owned subsidiary of Morgan Stanley, today announced an accelerated expansion plan across the Asia-Pacific region. This initiative reflects VRS’s long-term commitment to the region’s economic potential and its rapidly evolving investment demands.

Reference is made to the press release dated 3 June 2025, which stated that certain conditions under the purchase agreement had been fulfilled regarding the acquisition by Orkan IS ehf. (“Orkan”) of all shares held by Kaupfélag Suðurnesja (“KSK”) in Samkaup, with a nominal value of ISK 221,386,719, corresponding to 51.3% of the share capital in Samkaup.

ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that results from 13 studies of its core assets, including the novel drug olverembatinib (HQP1351) and the investigational EED inhibitor APG-5918, have been reported at the 2025 European Hematology Association (EHA) Annual Congress.

As XRP appears poised to surge to $3 in June, leading XRP mining platform PFMCrypto has launched a 48-hour exclusive XRP mining promotion, giving away $1 million USD in rewards to its global user base

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints